Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHematopoiesisHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesTissue DonorsNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsInfectionSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountImmunosuppressive AgentsPrednisoneCarboplatinHistocompatibility TestingLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineFollow-Up StudiesBlood Cell CountRecombinant ProteinsLeukemiaProspective StudiesAntineoplastic AgentsBone Marrow PurgingCytomegalovirus InfectionsLymphomaBlood CellsGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticLiver TransplantationBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCyclosporineLeukocytes, MononuclearT-LymphocytesHistiocytosis, Non-Langerhans-CellLivedo ReticularisPrognosisOpportunistic InfectionsHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensBone MarrowBlood DonorsImmunosuppressionBreast NeoplasmsMesenchymal Stem Cell TransplantationCell Separation